Burzynski Research Institute, Inc.
BZYR • Biotechnology
$0.00
— 0.00 (0.00%)
Current price
EarningsLatest report: Nov 30, 2025
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$262,896.888
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Weak liquidity · 0.02Weak profitability
Financial data as of: Nov 30, 2025, 12:00 AM UTCLast earnings update: Jan 13, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Shares Out131.45M
Market Cap$262.90K
Enterprise Value$260.73K
52W Range0.01 - 0.06
Beta0.27
P/E-0.20
P/B-3.90
P/FCF-0.26
EV/EBITDA-0.16
EV/FCF-0.26
Price$0.00
Change0.00%
Shares Out131.45M
Market Cap$262.90K
Enterprise Value$260.73K
52W Range0.01 - 0.06
Beta0.27
P/E-0.20
P/B-3.90
P/FCF-0.26
EV/EBITDA-0.16
EV/FCF-0.26
Earnings Yield-489.54%
FCF Yield-385.68%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio0.02
Quick Ratio0.02
Revenue 5Y-100.00%
Volume30.00K
Avg Volume9.17K
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
20/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
50/100
Why this score▼
Manageable debt level · 0Weak liquidity · 0.02Weak profitability
Analyst view
No analyst data available now.
🧾
No insider activity
No recent insider transactions available.